This week on Contemporary OB/GYN: January 16 to January 20
What's coming to Contemporary OBGYN® this week?
Alabama attorney general rescinds abortion pill prosecution statement
Alabama’s attorney general retracted comments he made last week suggesting criminal prosecution for women taking abortion pills for pregnancy termination. He is now saying that only providers who prescribe the pills could be prosecuted.
Daré Bioscience announces positive data on intravaginal ring for vasomotor and vaginal menopause symptoms
If approved, DARE-HRT1 would become the first FDA-approved monthly intravaginal ring to deliver both estrogen and progestin hormone therapy.
Is this a case of negligence?
In this month's Legally Speaking column, Hindi Stohl, MD, JD, and James M. Shwayder, MD, JD, dissect a case of shoulder and abdominal dystocia during a vaginal delivery for fetal hydrops.
Impact of cannabis legalization on prenatal marijuana use
Findings from a study in JAMA Network Open reveal valuable insight into the way cannabis legalization has impacted the perceptions of pregnant women who use cannabis in the US.
Proton pump inhibitor exposure in early pregnancy, risk of congenital malformations
Results of a study in JAMA Network Open sought to answer the question: Is proton pump inhibitor use during pregnancy associated with an increased risk of congenital malformations?
Do COVID-19 vaccines affect articifical insemination outcomes?
Many couples experiencing infertility are hesitant to get vaccined for COVID-19, resulting from misinformation on social media. A research letter in JAMA Network Open investigates the impact of COVID-19 vaccinations on artificial insemination-by-partner outcomes.
Check back soon for additional updates!
Importance of reproductive health services for adolescents during the COVID-19 pandemic
October 30th 2024In a recent study, high rates of reproductive health service use were reported among adolescent mothers, indicating the benefits of this model for providing care when other options are unavailable.
Read More
Increasing ondansetron use reported against NVP in the United States
October 29th 2024Despite being recommended as a third-line therapy, rates of ondansetron use to treat nausea and vomiting in pregnancy have increased, making it the most common prescription antiemetic against this condition in the United States.
Read More
Study finds high rates of incidental MRI findings in endometriosis cases
October 29th 2024A recent study highlights the frequent occurrence of incidental findings on pelvic magnetic resonance imaging for endometriosis, emphasizing the need for radiologists to focus on those with higher clinical significance.
Read More
